Epigenetic Clock Explains White Matter Hyperintensity Burden Irrespective of Chronological Age

Joan Jiménez-Balado1, Eva Giralt-Steinhauer1, Isabel Fernández-Pérez1

  • 1Neurovascular Research Group, Department of Neurology, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.

Biology
|January 21, 2023
PubMed

Insights

Biological age, determined by DNA methylation, significantly predicts white matter hyperintensities (WMH) volume in stroke patients, independent of chronological age. This epigenetic measure explains a substantial portion of WMH burden, offering new insights into stroke pathology.

Area of Science:

  • Neuroscience
  • Epigenetics
  • Gerontology

Background:

  • White matter hyperintensities (WMH) are common in acute stroke patients.
  • Biological age (B-age), estimated via DNA methylation, may offer insights into age-related brain changes beyond chronological age (C-age).

Purpose of the Study:

  • To investigate the association between B-age and WMH volume in acute stroke patients.
  • To determine if B-age influences WMH independently of C-age.

Main Methods:

  • Epigenetic data (DNA methylation) and magnetic resonance imaging (MRI) data were collected from 247 acute stroke patients.
  • WMH volume was quantified using a semi-automated method.
  • B-age was calculated using Hannum and Horvath epigenetic clocks; associations with WMH were analyzed using multiple linear regression, adjusting for C-age and other covariates.

Main Results:

  • B-age calculated using the Hannum formula (B-ageHannum) was significantly associated with increased WMH volume, independent of C-age.
  • B-ageHannum explained 42.7% of the effect of C-age on WMH volume.
  • B-age calculated using the Horvath formula (B-ageHorvath) did not show a significant association with WMH volume after adjusting for C-age.

Conclusions:

  • Epigenetic B-age (Hannum clock) is a significant predictor of WMH volume in acute stroke patients, irrespective of C-age.
  • This study highlights the role of epigenetic aging in the development of WMH, a key marker of cerebrovascular damage.